Cardio-Pad

Target Regions

Worldwide

Target SDGs

Market Suggested Retail Price

$3,299.00

Target Users (Target Impact Group)

Small and Medium-sized Enterprises

Distributors / Implementing Organizations

Cardio-Pad is distributed by Himore Medical to hospitals and health clinics.

Competitive Landscape

Direct competitors include Kit Cardiopad.

Manufacturing/Building Method

Mass produced at Himore Medical Equipments, located at Yaoundé, Cameroon.

Intellectural Property Type

Select Type

User Provision Model

Users can obtain this product directly from manufacturer, Cardio-Pad Kits are also distributed to hospitals and clinics in Cameroon free of charge, and patients pay 29 USD for yearly subscriptions.

Distributions to Date Status

A total of 300 devices have been manufactured as of April 2016.

Design Specifications

The Cardio-Pad is a 7-inch touch screen PC tablet powered by a lithium battery with a seven-hour charge. The motherboard is made up of a dual core processor Texas Instrument OMAP3530 (a ARMV4 processor with a 600 mHz speed and a DSP processor with a 200 mHz speed for digital signal processing), a DDR RAM of 256 MB, an internal memory of 2 GB, a GSM/GPRS for data transmission, a SIM card connector, a GPS module, a Bluetooth module to read patient data, a Wi-Fi module, two internal speakers and a microphone port. The Cardio Pad uses a personalized operating system (OS) developed from the Microsoft Windows CE 5.0 32-bit OS. The Cardio-Pad Kit consists of: Cardio-Pad, sensor, ECG cable, electrodes, tongs, panels, keyboard and mouse. The Cardio-Pad's main applications are to conduct ECG exams, monitor vitals, and transmit patient data to a trained cardiologist for interpretation.

Product Schematics

Technical Support

Provided by the Himore Medical team

Replacement Components

All components of the Cardio-Pad Kit can be purchased separately on the Himore Medical website.

Lifecycle

Unknown

Manufacturer Specified Performance Parameters

Performance targets include easy to use, quick diagnosis and reliable transmission of data.

Vetted Performance Status

The Cardio-Pad has proven 97.7% reliable in tests conducted in Cameroon.

Safety

Any appropriate standard for electrical safety (e.g., ANSI/AAMI ES-1, IEC 601-1) may be used.

Complementary Technical Systems

A reliable power source is needed to charge product every 7 hours.

Academic Research and References

Compliance with regulations

Unknown

Evaluation methods

This application was tested for rate of success in digital cardiac signal processing and the results compared with those of other researchers using the MIT MIB database